Global Insulin Pen Needles Market Growth 2025-2031

The global Insulin Pen Needles market size is predicted to grow from US$ 1321 million in 2025 to US$ 1875 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

Insulin Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. An insulin pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens. Pen needles come in a variety of needle lengths and diameters and are used by both health professionals and patients for injection of a variety of medications. They are commonly used by people with diabetes who often require multiple daily insulin injections.

The Insulin Pen Needles market is driven by the increasing prevalence of diabetes worldwide, leading to a growing demand for easy-to-use, convenient insulin delivery systems. Insulin pen needles provide a user-friendly and less painful alternative to traditional syringes, which is particularly appealing to patients managing diabetes on a daily basis. The rise in diabetes education, awareness, and self-management also contributes to the expanding adoption of insulin pens and their corresponding needles.

However, the market faces challenges, particularly in terms of pricing pressure and competition from low-cost alternatives. The availability of cheaper, non-branded needles may limit the growth potential for premium products. Additionally, concerns about waste management and the environmental impact of disposable needles can pose regulatory and societal challenges, pushing manufacturers to seek more sustainable solutions.

Global Insulin Pen Needles key players include BD, Novo Nordisk, Artsana, B. Braun, Terumo, etc. Global top five manufacturers hold a share about 70%. Europe is the largest market, with a share about 38%.

LP Information, Inc. (LPI) ' newest research report, the “Insulin Pen Needles Industry Forecast” looks at past sales and reviews total world Insulin Pen Needles sales in 2024, providing a comprehensive analysis by region and market sector of projected Insulin Pen Needles sales for 2025 through 2031. With Insulin Pen Needles sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insulin Pen Needles industry.

This Insight Report provides a comprehensive analysis of the global Insulin Pen Needles landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insulin Pen Needles portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insulin Pen Needles market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insulin Pen Needles and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insulin Pen Needles.

This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Pen Needles market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Standard Insulin Pen Needles
Safety Insulin Pen Needles

Segmentation by Application:
Home Use
Medical Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed Holding
Owen Mumford
Berpu Medical
KDL
Ulticare
Promisemed
Jiangxi Hongda Medical
Suzhou Shali Medical
Jiangsu Cai Nai Medical
Tianjin Huahong
Jiangsu Jichun Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Insulin Pen Needles market?

What factors are driving Insulin Pen Needles market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Insulin Pen Needles market opportunities vary by end market size?

How does Insulin Pen Needles break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.